| Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian countries T Bochenek, V Abilova, A Alkan, B Asanin, I de Miguel Beriain, Z Besovic, ... Frontiers in pharmacology 8, 942, 2018 | 121 | 2018 |
| Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients A Alkan, A Yaşar, E Karcı, EB Köksoy, M Ürün, FÇ Şenler, Y Ürün, ... Supportive Care in Cancer 25, 229-236, 2017 | 96 | 2017 |
| Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee … A Alkan, ZG Guc, FC Senler, T Yavuzsen, H Onur, M Dogan, E Karci, ... Supportive Care in Cancer 24, 3747-3755, 2016 | 33 | 2016 |
| The efficacy of esmolol, remifentanil and nitroglycerin in controlled hypotension for functional endoscopic sinus surgery A Alkan, M Honca, A Alkan, H Güleç, E Horasanlı Brazilian journal of otorhinolaryngology 87 (3), 255-259, 2021 | 30 | 2021 |
| The social media disorder and ostracism in adolescents:(OSTRACA-SM Study) G Ergun, A Alkan The Eurasian journal of medicine 52 (2), 139, 2020 | 28 | 2020 |
| Vitamin D deficiency in cancer patients and predictors for screening (D-ONC study) A Alkan, EB Köksoy Current problems in cancer 43 (5), 421-428, 2019 | 19 | 2019 |
| The effects of nurses’ empathy skills on attitudes towards patients with cancer A Alkan Journal of Clinical and Experimental Investigations 8 (2), 70-74, 2017 | 19 | 2017 |
| Albumin to globulin ratio, a predictor or a misleader? A Alkan, EB Köksoy, G Utkan Annals of Oncology 26 (2), 443-444, 2015 | 19 | 2015 |
| Vaccination in oncology practice and predictors A Alkan, E Karcı, A Yaşar, G Tuncay, EB Köksoy, M Ürün, FÇ Şenler, ... Supportive Care in Cancer 25, 2677-2682, 2017 | 18 | 2017 |
| Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy C Karacin, B Oksuzoglu, A Demirci, M Keskinkılıç, NK Baytemür, F Yılmaz, ... BMC cancer 23 (1), 136, 2023 | 17 | 2023 |
| Interstitial pneumonitis associated with trastuzumab emtansine A Alkan Journal of Oncology Pharmacy Practice 25 (7), 1798-1800, 2019 | 17 | 2019 |
| Ga-68 PSMA accumulation in hepatocellular carcinoma C Soydal, A Alkan, E Ozkan, A Demirkazık, NO Kucuk Clin Oncol 1, 1091, 2016 | 17 | 2016 |
| Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: results of real-life experiences D Tural, ÖF Ölmez, AT Sümbül, M Artaç, N Özhan, E Akar, B Çakar, ... European urology focus 7 (5), 1061-1066, 2021 | 15 | 2021 |
| Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab D Tural, ÖF Ölmez, AT Sümbül, N Özhan, B Çakar, O Köstek, M Ekenel, ... International journal of clinical oncology 26, 1506-1513, 2021 | 15 | 2021 |
| Posttraumatic growth and death anxiety in caregivers of cancer patients: PHOENIX study A Alkan, EB Köksoy, E Karci, A Alkan, E Bruera, FÇ Şenler Turkish journal of medical sciences 50 (5), 1364-1370, 2020 | 15 | 2020 |
| Double-edged sword: Granulocyte colony stimulating factors in cancer patients during the COVID-19 era A Alkan, A Uncu, I Taşkıran, Ö Tanrıverdi Clinics 75, e2033, 2020 | 14 | 2020 |
| Efficacy and safety of trastuzumab emtansine in HER2 positive metastatic breast cancer: real-world experience A Bahçeci, S Paydaş, N Ak, F Ferhatoğlu, PM Saip, G Seydaoğlu, M Bilici, ... Cancer investigation 39 (6-7), 473-481, 2021 | 13 | 2021 |
| Docetaxel-induced pericardial effusion SE Dogan, D Mizrak, A Alkan, A Demirkazik Journal of Oncology Pharmacy Practice 23 (5), 389-391, 2017 | 12 | 2017 |
| Spatial, temporal, and vertical variability of nutrients in the Southeastern Black Sea A Alkan, S Serdar, D Fidan, U Akbaş, B Zengin, MB Kiliç Chemosphere 302, 134809, 2022 | 11 | 2022 |
| Nurses’ Knowledge Levels about Port Catheter Care (POCATH Study): a study of the palliative care working committee of the Turkish Oncology Group (TOG) A Alkan Journal of Clinical and Experimental Investigations 8 (2), 75-79, 2017 | 11 | 2017 |
